Lexicon Pharmaceuticals is positioned for a potential turnaround with three key drug programs and recent partnerships, ...

ConocoPhillips offers long-term FCF growth with cost discipline, oil leverage, flexible assets and projects adding value. See ...

Micron advances with AI growth, strong results, a geopolitical moat, DCF upside near 375, and risks requiring prudent entry.

Niagen Bioscience posts record Q3 revenue, boosted by Tru Niagen and new partnerships. Read here for an investment analysis ...

WisdomTree's record growth and Ceres acquisition offer a strong buy opportunity. Read here for latest insights and investment ...

In terms of income, as it focuses on earnings, EPS is doing slightly better than the S&P 500. The fund is distributing a ...

DLocal posts strong TPV growth in Q3 despite pricing concerns. I estimate DLO stock to have 42% upside to $19.2. See more ...

Boston Omaha shows negative earnings, slowed revenue, estimate misses, weak investments and limited upside with an $11 target ...

Domino's delivers strong Q3 gains, value-led sales growth, a franchise model, and international expansion boosting sales. See ...

Church & Dwight posts robust Q3 with 5% growth, strong volumes, raised guidance and cost control plus buybacks and acq. Read ...

Discover how HNST boosts profits by targeting high-margin segments and channels. Learn about their solid balance sheet and ...

Marten Transport offers a debt-free profile, insider ownership, temp-controlled strength, steady profits and a young fleet.